Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: Results of an observational open controlled parallel group study in real-life setting

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 4, 2005, Pages 135-142

  Marogna, M ^a   Spadolini, I ^b   Massolo, A ^c  

^a OSPEDALE DI CIRCOLO   (Italy)

^b Anallergo SpA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Allergic March; Observational Study; Specific Immunotherapy

Indexed keywords

ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; CETIRIZINE; CORTICOSTEROID; IMMUNOMODULATING AGENT; LORATADINE; METHACHOLINE; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL OBSERVATION; COMORBIDITY; CONTROLLED STUDY; DERMATOPHAGOIDES; DISEASE SEVERITY; FEMALE; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; INCIDENCE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PARALLEL DESIGN; RESPIRATORY TRACT ALLERGY; RHINITIS; SCHOOL CHILD; SELF MEDICATION;

ADOLESCENT; ADULT; ANIMALS; ANTI-ALLERGIC AGENTS; ASTHMA; BRONCHIAL PROVOCATION TESTS; CHILD; COMBINED MODALITY THERAPY; COMORBIDITY; DESENSITIZATION, IMMUNOLOGIC; DISEASE PROGRESSION; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFECTION; ITALY; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PYROGLYPHIDAE; RESPIRATORY FUNCTION TESTS; RESPIRATORY HYPERSENSITIVITY; RHINITIS, ALLERGIC, PERENNIAL; SEVERITY OF ILLNESS INDEX;

EID: 18744403679     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Corren J. - The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 1998;101:S352.
2. Aria Consensus. - Allergic Rhinitis and its impact on Asthma. ARIA workshop Report 2001. J Allergy Clin Immunol 2001;108(5 Suppl.):147-337.
3. Juniper E.-F. - Quality of life in adults and children with asthma and rhinitis. Allergy 1997;52(10):971.
4. Yawn B.-P. et al. - Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clinical Immunol 1999;103:54.
5. Olivieri M., Verlato G., Corsico A. et al. - Prevalence and features of allergic rhinitis in Italy. Allergy 2002;57:600-6.
6. Dreborg S., Frew A. (Eds.). - EAACI Subcommittee on Allergen Standardization and Skin tests. Position paper: Allergen standardization and skin tests. Allergy 1993;48(14 suppl.):48-82.
7. Sterk P.-J., Fabbri L-M., Quanjer Ph.-H. et al. - Airway responsiveness standardized challenge testing with pharmacological, physical and sensitising stimuli in adults. Official statement of the European Respiratory Society. Eur Resp J 1993;Vol 6, Suppl. 16:53-83.
8. Plaschke P.-P., Janson C., Norrman E. et al. - Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Resp Crit Care Med 2000; 162 (Part 1):920-4.
9. Magyar P., Dervaderies M., Toth A., Lantos A. - Inhalation of hypertonic potassium chloride solution: a specific bronchial challenge for asthma. Giorn It Mal Tor 1983;37:29.
10. Mailing H.-J., Weeke B. - Immunotherapy position paper. Allergy 1983;Suppl. 48:14.
11. WHO position paper. - Allergen immunotherapy: Therapeutic vaccines for allergic disease. Allergy 1998;53:1.
12. Global Initiative for Asthma: guidelines for the diagnosis and management of asthma. NIH publication 1997;97-4051.
13. Prieto J.-L., Gutierrez V., Berto J.-M. et al. - Sensitivity and maximal response to methacoline in perennial and seasonal allergic rhinitis. Clin Exp Allergy 1996;26:61-7.
14. rd edition. WH Freeman & C, New York, 1995.
15. nd edition. Springer Verlag, 2002.
16. Bergmann R.-L., Edenharter G., Bergmann K.-E. et al. - Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998; 28: 965-70.
17. Warner J.-O., for the ETAC Study Group. A double-blinded, randomised, placebo-controlled trial of cetirizine in preventing the oncet of asthma in children with atopic dermatitis: 18 months treatment and 18 months post-treatment follow-up. J Allergy Clin Immunol 2001; 108: 929-937.
18. WHO Position Paper. - Allergen immunotherapy: terapeutical vaccines for allergic diseases. Bousquet J, Lockey R., Maling HJ (eds.). Allergy 1998;53 (suppl. 54).
19. Johnstone D.-E., Dutton A. - The value of hyposensitization therapy for bronchial asthma in children- a 14-year study. Pediatrics 1968;42:793-802.
20. Durham S.-R., Till S.-J. - Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-64.
21. Frew A.-J. - Immunotherapy of allergic disease. J Allergy Clin Immunol 2003;111(Suppl):S7 12-9.
22. Waldmann T-A. - Immunotherapy: past, present and future. Nat Med 2003;9:269-77.
23. Wilson D.-R., Torres Lima M., Durham S.-R. - Sublingual immunotherapy for allergic rhinitis (Cochrane Rewiew). The Cochrane Library, Issue 2, 2003.
24. Silvestri M., Rossi G.-A., Cozzani S. et al. Age-dependent tendency to become sensitised to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol 1999;83: 335-340.
25. Des Roches A., Paradis L., Menardo J.-L. et al. - Immunotherapy with a standardized Dermatophagoides pteronissimus extract VI.Specific immunotherapy prevents the oncet of new sensitizations in children. J Allergy Clin Immunol 1997;99:450-453.
26. Purello D'Ambrosio F., Gangemi S., Merendino R.-A. et al. - Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001;31:1295-1302.
27. Pajno G.-B., Barberio G., De Luca F. et al. - Prevention of new sensitisations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-1397.
28. Marogna M., Massolo A. - Sublingual immunotherapy in the contest of a clinical practice improvement program in the allergological setting: results of a long term observational study. Eur Ann Allergy Clin Immunol 2003;35:133-140.
29. Passalacqua G., Canonica G.-W. - Long-lasting clinical efficacy of allergen specific immunotherapy. Allergy 2002;57:275-276.
30. Eng P.-A., Reinhold M., Gnehm HPE. - Long-term efficacy of pre-seasonal grass pollen immunotherapy in children. Allergy 2002;57:306-312.
31. Di Rienzo V., Marcucci F., Puccinelli P. et al. - Long-lasting effects of sublingual immunotherapy in children with asthma due to house dust mite: a ten-year prospective study. Clin Exp Allergy 2003;33:206-210.
32. Marogna M., Tiri A., Riva G. - Clinical practice improvement program for immunotherapy of respiratory allergic diseases. Int J Immunopath Pharmacol 2001;14:93-101.
33. Kleijnen J., De Craen A.-J., Van Everdingen J. et al. - Placebo effect in double blind clinical trials: a rewiew of its interaction with medications. Lancet 1994;344:1347-1349.